PQA has published the 2025 PQA Annual Report, which documents progress towards our strategic plan, Blueprint PQA 2025, from September 2024 to August 2025. Alongside our members and stakeholders, our team continues to advance a series of important, enduring and mutually supporting goals. Together, we are innovating and expanding capacity to enable quality medication use in a digital, value-based health system.

All too often, strategic plans are placed in a desk drawer and gather dust as the years pass. Our plan and strategic goals, however, have served PQA well and successfully guided our work each year. We have learned by experience and finetuned our approach, making continual and positive progress in support of our overall plan and PQA’s mission.

Some of the highlights featured in this report include:

• Launching phase two of PQA’s groundbreaking work related to oral anticancer medications;
• Advancing strategies to improve medication therapy management quality;
• Piloting pharmacy-based immunization measure concepts in value-based arrangements;
• Hosting the PQA Annual Meeting, Leadership Summit, and a special forum on rare disease;
• Expanding education and training for professionals and students, including the Diverse Quality Leaders Program; and
• Modernizing PQA’s technology ecosystem to improve user experience and maximize stakeholder participation and engagement with PQA.

There are still numerous opportunities to be involved with PQA and impact quality medication use in 2025. 

• PQA Convenes: Artificial Intelligence in Medication Use Quality, on November 13, in Arlington, Va. 
• 2025 PQA Leadership Summit, November 13-14, in Arlington, Va. 
• A measure vote opportunity, follow the PQA Measure Endorsement and Retirement Meeting, on September 18, from 1-2 p.m. ET.
• Fourth Quarter PQA Stakeholder Advisory Meeting, on October 22, from 1-2 p.m. ET. 
• 2026 PQA Annual Meeting proposals are now being accepted for breakout sessions and poster abstracts. 
• Applications are open for PQA's student and young professionals programs.

On behalf of our entire team and the PQA Board of Directors, thank you for your engagement, contributions and support in ensuring our success. The accomplishments detailed in this report are shared and celebrated by us all. They would not be possible without your collaboration with PQA and our multi-stakeholder member organizations, all of whom are committed to improving medication use quality outcomes for patients.

We are looking forward to 2026, in which we will celebrate PQA’s 20th anniversary. Meanwhile, our work on the current blueprint continues as we plan for the next five years and Blueprint PQA 2030. Not sure how to get involved? Reach out to us at [email protected] for  assistance!